欧洲标准局IRMM JRC 参考物质证书 EURM-018_Antibodies against SARS-CoV-2 product information sheet version2.pdfVIP

JOINT RESEARCH CENTRE Directorate F – Health, Consumers and Reference Materials REFERENCE MATERIAL PRODUCT INFORMATION SHEET EURM-018 HUMAN SERUM Antibodies against SARS-CoV-2 Neutralising antibodies1) present Antibodies against the nucleocapsid protein of SARS-CoV-22) present Antibodies against the spike protein of SARS-CoV-22) present Antibodies against the receptor binding domain (RBD) of the spike protein present of SARS-CoV-22) 1) The presence of the neutralising antibodies was confirmed by seven different virus neutralisation assays performed by six different laboratories (see details under measurement results) 2) The presence of these antibodies was confirmed by various immunoassays performed by different laboratories (see details under measurement results). This product information sheet is valid for three months after purchase. Sales date: The minimum amount of sample to be used is 5 µL. Geel, December 2020 Latest revision: February 2021 Signed: Dr Robert Koeber Head of Unit Reference Materials European Commission, Joint Research Centre Directorate F – Health, Consumers and Reference Materials Retieseweg 111 B-2440 Geel, Belgium